Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
European Journal of Pain (London, England)
|
November 23, 2006
Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects
Olav Magnus S Fredheim, Petter C Borchgrevink, Pål Klepstad, et al.
European Journal of Clinical Pharmacology
|
March 1, 2012
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain
Kristin Moksnes, Stein Kaasa, Ørnulf Paulsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 12, 2005
[Application of pupillometry and pupillary reactions in medical research]
Solveig Sandven Kjesbu, Kristin Moksnes, Pål Klepstad, et al.
European Journal of Clinical Pharmacology
|
February 2, 2017
Pharmacokinetics of a new, nasal formulation of naloxone
Ida Tylleskar, Arne Kristian Skulberg, Turid Nilsen, et al.
Resuscitation
|
August 24, 2010
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest
Thor Wilhelm Bjelland, Øyvind Hjertner, Pål Klepstad, et al.
Drugs
|
July 29, 2019
Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
John Strang, Rebecca McDonald, Gabrielle Campbell, et al.
Anesthesia and Analgesia
|
February 26, 2004
Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery
Hilde Pleym, Roar Stenseth, Alexander Wahba, et al.
Addiction (Abingdon, England)
|
January 16, 2019
Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial
Arne Kristian Skulberg, Anders Åsberg, Hasse Zare Khiabani, et al.
Pharmacogenetics and Genomics
|
January 2, 2013
Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain
Torill Fladvad, Pål Klepstad, Mette Langaas, et al.
Journal of Pain and Symptom Management
|
August 1, 2006
Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study
Olav Magnus S Fredheim, Petter C Borchgrevink, Lars Hegrenaes, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
European Journal of Pain (London, England)
|
November 23, 2006
Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects
Olav Magnus S Fredheim, Petter C Borchgrevink, Pål Klepstad, et al.
European Journal of Clinical Pharmacology
|
March 1, 2012
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain
Kristin Moksnes, Stein Kaasa, Ørnulf Paulsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 12, 2005
[Application of pupillometry and pupillary reactions in medical research]
Solveig Sandven Kjesbu, Kristin Moksnes, Pål Klepstad, et al.
European Journal of Clinical Pharmacology
|
February 2, 2017
Pharmacokinetics of a new, nasal formulation of naloxone
Ida Tylleskar, Arne Kristian Skulberg, Turid Nilsen, et al.
Resuscitation
|
August 24, 2010
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest
Thor Wilhelm Bjelland, Øyvind Hjertner, Pål Klepstad, et al.
Drugs
|
July 29, 2019
Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
John Strang, Rebecca McDonald, Gabrielle Campbell, et al.
Anesthesia and Analgesia
|
February 26, 2004
Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery
Hilde Pleym, Roar Stenseth, Alexander Wahba, et al.
Addiction (Abingdon, England)
|
January 16, 2019
Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial
Arne Kristian Skulberg, Anders Åsberg, Hasse Zare Khiabani, et al.
Pharmacogenetics and Genomics
|
January 2, 2013
Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain
Torill Fladvad, Pål Klepstad, Mette Langaas, et al.
Journal of Pain and Symptom Management
|
August 1, 2006
Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study
Olav Magnus S Fredheim, Petter C Borchgrevink, Lars Hegrenaes, et al.
Page
of 7